Stock Region Penny Picks
The Stock Region Penny Picks Watchlist - Wednesday, October 22, 2025
The Stock Region Penny Picks Watchlist
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Hold up! Before you dive in, remember this is all for informational and entertainment purposes. We’re a community of traders sharing our thoughts, not a team of financial advisors. The stock market is a wild ride, and all investments carry risk. Do your own research and make decisions that are right for you. Never invest more than you are willing to lose.
What a day, traders! The market was buzzing with action, and if you weren’t paying attention, you definitely missed some explosive moves. We saw biotech making waves, defense contracts landing, and even some intriguing developments in the rare earth metals space. Let’s break down the news that had our screens glowing today.
Today’s Top Movers & Shakers
$MOBX - Mobix Labs
Talk about a power play. Mobix Labs secured a multi-year follow-on contract with the U.S. Navy. Any time you see “U.S. Navy” and “multi-year” in the same sentence, it’s a major signal of stability and trust. This isn’t just a one-off deal; it’s a relationship. This move helps solidify their position in the defense sector, which is always a bonus. Keep this one on your radar; government contracts can mean consistent revenue streams.
$BDSX - Biodesix
Biodesix is deepening its partnership with Bio-Rad Labs. This is a solid strategic move. Instead of trying to do everything themselves, they’re teaming up with an established name to develop high-complexity assays. This kind of collaboration can accelerate development and get products to market faster. It’s a smart play that shows the company is focused on growth and innovation.
$BCTX - BriaCell
Here’s some news that really matters. BriaCell got a positive recommendation from the Data Safety Monitoring Board for its Phase 3 study in metastatic breast cancer. This is a huge hurdle to clear. A green light from the DSMB means the trial is on the right track from a safety perspective, allowing them to continue their crucial work. While it’s still a long road, this is an incredibly encouraging milestone for the company and for patients. We’re rooting for them.
$BLBX - Blackboxstocks Inc.
This is a complex but fascinating story. Blackboxstocks’ merger target, REAlloys Inc., just signed a strategic MOU with the Japanese government’s “JOGMEC.” The goal? To strengthen the U.S. and Japan’s rare earth supply chain. With all the global focus on securing critical resources, this puts REAlloys (and by extension, BLBX post-merger) right in the middle of a massive geopolitical and economic trend. This is a long-term story to watch unfold.
$SBEV - Splash Beverage Group
Wow! $SBEV absolutely ripped today, jumping 45% to $2.74. The catalyst? The company’s CFO, William T. Devereux, reported a massive 29.4% stake. When a high-level insider puts that much of their own skin in the game, it screams confidence. This is the kind of “put your money where your mouth is” move that gets the market’s attention in a big way.
$ARMP - Armata Pharmaceuticals
The stock was halted on its way up after announcing positive results from its Phase 2a study. They are developing a bacteriophage cocktail to fight Staph infections, a massive problem in healthcare. Presenting “late-breaking” data at a major conference like IDWeek adds a layer of prestige and urgency. This is a significant step forward in their clinical journey.
$VTYX - Ventyx Biosciences
Obesity drugs are one of the hottest sectors right now, and Ventyx just threw its hat in the ring with positive topline results from its Phase 2 study. The market is hungry for new players in this space. While it’s still early days, a successful trial here could position VTX3232 as a serious contender. This is definitely one to watch closely as they move toward Phase 3.
$SLE - Super League
Super League announced a $15.25 million private placement. The key here is that it was led by a “strategic digital asset investor” and helps them meet Nasdaq requirements. This is about shoring up the balance sheet and securing their spot on a major exchange. It’s a move to build a stronger foundation for whatever comes next.
That’s a wrap for today’s highlights. It was a day filled with powerful catalysts and reminders of why we love the game. Stay sharp, do your homework, and get ready for what tomorrow brings.
Final Disclaimer: Seriously, we mean it. The information in this newsletter is not investment advice, a recommendation, or a solicitation to buy or sell any securities. We may or may not hold positions in the stocks mentioned. Trading involves substantial risk, and you can lose a lot of money. Always perform your own due diligence before making any investment decisions.